跳至主要内容
临床试验/RBR-6tnw2b
RBR-6tnw2b尚未招募2 期

Phase II clinical trial, prospective, double-blind, randomized, placebo-controlled trial for the evaluation of G-CSF in patients with chronic Chagas cardiomyopathy

Fundação Oswaldo Cruz0 个研究点开始时间: 2014年5月28日最近更新:

试验速览

阶段
2 期
状态
尚未招募

研究概览

简要总结

暂无简介。

研究设计

研究类型
Intervention

入排标准

年龄范围
20Y 至 70Y(—)

入选标准

  • Diagnosis of Chagas' disease confirmed by two serological tests with different methodologies; Diagnosis of Chagas' cardiomyopathy in functional classes II, III and NYHA IV heart failure; Availability and willingness to participate, given the schedule of the study; Agreement and signing the consent form.

排除标准

  • -Acute systemic infections; Solid Malignancies, myelodysplasia, acute myeloid leukemia or chronic, confirmed by imaging studies or past medical history; Valvular with hemodynamic consequences;
  • Autoimmune, pulmonary, or degenerative diseases, confirmed by imaging studies or past medical history; Renal dysfunction, severe liver or thyroid, confirmed by imaging studies or past medical history;
  • Pregnancy (confirmed by examination of ? HCG) or lactation; Known hypersensitivity to G-CSF or to other components of the formula and / or hypersensitivity to proteins derived from E. coli.

研究者

相似试验